Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Why now is the perfect time to buy these 3 super income stocks

| Peter Stephens

These three shares look set to deliver strong returns over the medium-to-long term and the interest rate cut could make…

Read more »

Investing Articles

Are these the FTSE 100’s ‘safest’ dividend stocks?

| Royston Wild

Royston Wild reveals four FTSE 100 (INDEXFTSE: UKX) giants with terrific payout prospects.

Read more »

Investing Articles

Tech vs biotech: Is AstraZeneca plc or Apple Inc. the better buy?

| Prabhat Sakya

Should you invest in biotech giant AstraZeneca plc (LON:AZN) or consumer king Apple Inc. (NASDAQ:AAPL)?

Read more »

Investing Articles

Should you take a look at these 3 shares after today’s news?

| Jack Dingwall

Three great shares to keep an eye on for future investment potential.

Read more »

Investing Articles

3 post-Brexit picks I’d buy now

| Prabhat Sakya

Barratt Developments plc (LON:BDEV), Aviva plc (LON:AV) and AstraZeneca plc (LON:AZN) are three candidates for your watch list.

Read more »

Investing Articles

Here’s what Neil Woodford has been buying and selling since the Brexit vote

| G A Chester

How has the UK's most renowned investor reacted to the referendum result? Here's what Neil Woodford has been up to.

Read more »

Investing Articles

Will GlaxoSmithKline plc and AstraZeneca plc continue to be Brexit winners?

| Harvey Jones

Brexit isn't the only factor driving recent share price growth at GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN),…

Read more »

Investing Articles

3 shares Neil Woodford backs despite Brexit ‘sideshow’

| Kevin Godbold

Britain's well-respected fund manager sees bigger problems for Britain than Brexit. This is what he holds to defend against them.

Read more »

Investing Articles

Are AstraZeneca plc, Purplebricks Group plc and Hargreaves Lansdown plc doomed to fail?

| Peter Stephens

Should you avoid these three stocks? AstraZeneca plc (LON: AZN), Purplebricks Group plc (LON: PURP) and Hargreaves Lansdown plc (LON:…

Read more »

Investing Articles

Why Brexit has doomed your pension

| Rupert Hargreaves

Brexit has sent shockwaves through the financial world and could have doomed some workers' pensions.

Read more »

Investing Articles

Banish your Brexit fears with Vodafone Group plc, AstraZeneca plc and Reckitt Benckiser Group plc!

| Royston Wild

Royston Wild explains why Vodafone Group plc (LON: VOD), AstraZeneca plc (LON: AZN) and Reckitt Benckiser Group plc (LON: RB)…

Read more »

Investing Articles

3 dates for your July investing diary (Tullow Oil plc, Anglo American plc and AstraZeneca plc)

| Alan Oscroft

Can Tullow Oil plc (LON: TLW), Anglo American plc (LON: AAL) and AstraZeneca plc (LON: AZN) provide calm during the…

Read more »